2024

• Mantzourani, E., James, D., Akthar, M., Brown, S., Yemm, R., Lehnbom, E., Hanrahan, J., Seage, C. (2024). Can a mock medication-taking learning activity enable pharmacy students to experience the range of barriers and facilitators to medication adherence? An analysis informed by the Theoretical Domains Framework and COM-B model. Exploratory Research in Clinical and Social Pharmacy, 13. [More Information]
• Chan, W., Beale, P., McLachlan, A., Hanrahan, J., Harnett, J. (2024). The safety and tolerability of Annona muricata leaf product in people living with cancer: Study protocol. Advances in Integrative Medicine. [More Information]

2023

• Al Kazman, B., Harnett, J., Hanrahan, J. (2023). Identification of Annonaceous Acetogenins and Alkaloids from the Leaves, Pulp, and Seeds of Annona atemoya. International Journal of Molecular Sciences, 24(3). [More Information]

2022

• Naffaa, M., Hibbs, D., Collins, M., Hanrahan, J. (2022). Pharmacological Effect of GABA Analogues on GABA-ϱ2 Receptors and Their Subtype Selectivity. Life, 12(1), 127. [More Information]
• Naffaa, M., Hibbs, D., Chebib, M., Hanrahan, J. (2022). Roles of hydrophilic residues in GABA binding site of GABA-ρ1 receptor explain the addition/inhibition effects of competitive ligands. Neurochemistry International, 153, 105258. [More Information]
• Al Kazman, B., Harnett, J., Hanrahan, J. (2022). Traditional Uses, Phytochemistry and Pharmacological Activities of Annonacae. Molecules, 27(11). [More Information]

2021

• Trapika, I., Liu, X., Chung, L., Lai, F., Xie, C., Zhao, Y., Cui, S., Chen, J., Tran, C., Wang, Q., Don, A., Li, G., Hanrahan, J., Qi, J., et al (2021). Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers. Frontiers in Oncology, 11, 738078. [More Information]
• Carroll, P., Hanrahan, J. (2021). Development and evaluation of an interprofessional student-led influenza vaccination clinic for medical, nursing and pharmacy students. Pharmacy Practice, 19(4), 1-12. [More Information]
• van Nieuwenhuijzen, P., Parker, K., Liao, V., Houlton, J., Kim, H., Johnston, G., Hanrahan, J., Collins, M., Clarkson, A. (2021). Targeting GABAc Receptors Improves Post-Stroke Motor Recovery. Brain Sciences, 11(3), 315-1-315-19. [More Information]

2020

• Lee, K., Tan, E., Hanrahan, J., Chircop, C., Michael, F., Ong, J. (2020). Effect of Antipsychotics and Non-Pharmacotherapy for the Management of Delirium in People Receiving Palliative Care. Journal of Pain & Palliative Care Pharmacotherapy, 34(4), 225-236. [More Information]
• Carroll, P., Chen, Y., Vicheth, P., Webber, P., Hanrahan, J. (2020). Evaluation of a vaccination training program for pharmacy graduands in Australia. Currents in Pharmacy Teaching and Learning, 12(7), 850-857. [More Information]
• Hanrahan, J., Carroll, P. (2020). Student-led interprofessional influenza vaccination clinic in a time of coronavirus. Medical Education, 54(11), 1078-1079. [More Information]
• Al Kazman, B., Harnett, J., Hanrahan, J. (2020). The phytochemical constituents and pharmacological activities of annona atemoya: A systematic review. Pharmaceuticals, 13(10), 1-16. [More Information]
• Chan, W., McLachlan, A., Hanrahan, J., Harnett, J. (2020). The safety and tolerability of Annona muricata leaf extract: a systematic review. Journal of Pharmacy and Pharmacology, 72(1), 1-16. [More Information]

2019

• Solomon, V., Tallapragada, V., Chebib, M., Johnston, G., Hanrahan, J. (2019). GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators. European Journal of Medicinal Chemistry, 171, 434-461. [More Information]
• Devenish, S., Johnston, G., Chebib, M., Hanrahan, J. (2019). Optimising the transient expression of GABA(A) receptors in adherent HEK293 cells. Protein Expression and Purification, 154, 7-15. [More Information]
• Clarkson, A., Boothman-Burrell, L., Dosa, Z., Nagaraja, R., Jin, L., Parker, K., van Nieuwenhuijzen, P., Neumann, S., Gowing, E., Gavande, N., Ahring, J., Hanrahan, J., Chebib, M., et al (2019). The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemia. Journal of Cerebral Blood Flow and Metabolism, 39(7), 1266-1282. [More Information]

2018

• Du, J., Hanrahan, J., Solomon, V., Williams, P., Groundwater, P., Overgaard, J., Platts, J., Hibbs, D. (2018). Exploring the Binding of Barbital to a Synthetic Macrocyclic Receptor. A Charge Density Study. The Journal of Physical Chemistry A, 122(11), 3031-3044. [More Information]

2017

• Carroll, P., Hanrahan, J. (2017). A shot in the arm: Pharmacist-Administered influenza vaccine in New South Wales. Australian Journal of Pharmacy, 98(1165), 56-59. [More Information]
• Nematollahi, A., Sun, G., Jayawickrama, G., Hanrahan, J., Church, W. (2017). Crystal structure and mechanistic analysis of a novel human kynurenine aminotransferase-2 reversible inhibitor. Medicinal Chemistry Research, 26(10), 2514-2519. [More Information]
• Hinton, T., Hanrahan, J., Johnston, G. (2017). Flavonoid Actions on Receptors for the Inhibitory Neurotransmitter GABA. In Goncalo C Justino (Eds.), Flavonoids: From Biosynthesis to Human Health, (pp. 335-350). Rijeka: InTech. [More Information]
• Naffa'a, M., Hung, S., Chebib, M., Johnston, G., Hanrahan, J. (2017). GABA-(rho) receptors: distinctive functions and molecular pharmacology. British Journal of Pharmacology, 174(13), 1881-1894. [More Information]
• Abdelhalim, A., Aburjai, T., Hanrahan, J., Abdel-Halim, H. (2017). Medicinal plants used by traditional healers in Jordan, the Tafila region. Pharmacognosy Magazine, 13(49), S95-S101. [More Information]
• Karim, N., Khan, I., Abdelhalim, A., Abdel-Halim, H., Hanrahan, J. (2017). Molecular docking and antiamnesic effects of nepitrin isolated from Rosmarinus officinalis on scopolamine-induced memory impairment in mice. Biomedicine and Pharmacotherapy, 96, 700-709. [More Information]
• Wong, C., Marshall, N., Grunstein, R., Ho, S., Fois, R., Hibbs, D., Hanrahan, J., Saini, B. (2017). Spontaneous adverse event reports associated with zolpidem in the United States 2003-2012. The Journal of Clinical Sleep Medicine, 13(2), 223-234. [More Information]

2016

• Lee, H., Absalom, N., Hanrahan, J., van Nieuwenhuijzen, P., Ahring, J., Chebib, M. (2016). A pharmacological characterization of GABA, THIP and DS2 at binary alpha4Beta3 and Beta3delta receptors: GABA activates Beta3delta receptors via the Beta3(+)delta(-) interface. Brain Research, 1644, 222-230. [More Information]
• Hamid, K., Ng, I., Tallapragada, V., Varadi, L., Hibbs, D., Hanrahan, J., Groundwater, P. (2016). An investigation of the differential effects of ursane triterpenoids from Centella asiatica, and their semi-synthetic analogues, on GABAA receptors. Chemical Biology & Drug Design, 88(3), 386-397. [More Information]
• Naffa'a, M., Absalom, N., Solomon, V., Collins, M., Hibbs, D., Hanrahan, J. (2016). Investigating the Role of Loop C Hydrophilic Residue 'T244' in the Binding Site of (rho)1 GABAC Receptors via Site Mutation and Partial Agonism. PloS One, 11(5), 1-21. [More Information]
• Nematollahi, A., Sun, G., Harrop, S., Hanrahan, J., Church, W. (2016). Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel Spacegroup at 1.83 A Resolution. International Journal of Molecular Sciences, 17(4), 1-11. [More Information]
• Nematollahi, A., Sun, G., Jayawickrama, G., Hanrahan, J., Church, W. (2016). Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders. Molecules, 21(7), 1-9. [More Information]

2015

• Carland, J., Yamamoto, I., Hanrahan, J., Abdel-Halim, H., Lewis, T., Absalom, N., Chebib, M. (2015). A Hydrophobic Area of the GABA p1 Receptor Containing Phenylalanine 124 Influences Both Receptor Activation and Deactivation. Journal of Molecular Neuroscience, 55(2), 305-313. [More Information]
• Abdelhalim, A., Karim, N., Chebib, M., Aburjai, T., Khan, I., Johnston, G., Hanrahan, J. (2015). Antidepressant, Anxiolytic and Antinociceptive Activities of Constituents from Rosmarinus Officinalis. Journal of Pharmacy and Pharmaceutical Sciences, 18(4), 448-459. [More Information]
• Naffa'a, M., Chebib, M., Hibbs, D., Hanrahan, J. (2015). Comparison of templates for homology model of rho1 GABAC receptors: More insights to the orthosteric binding site's structure and functionality. Journal of Molecular Graphics and Modelling, 62, 43-55. [More Information]
• Hanrahan, J., Chebib, M., Johnston, G. (2015). Interactions of flavonoids with ionotropic GABA receptors. Advances in Pharmacology, 72, 189-200. [More Information]
• Jayawickrama, G., Sadig, R., Sun, G., Nematollahi, A., Nadvi, N., Hanrahan, J., Gorrell, M., Church, W. (2015). Kynurenine aminotransferases and the prospects of inhibitors for the treatment of schizophrenia. Current Medicinal Chemistry, 22(24), 2902-2918. [More Information]
• Rae, C., Nasrallah, F., Balcar, V., Rowlands, B., Johnston, G., Hanrahan, J. (2015). Metabolomic Approaches to Defining the Role(s) of GABAI Receptors in the Brain. Journal of Neuroimmune Pharmacology, 10(3), 45-456. [More Information]
• Bui, J., Day, C., Hanrahan, J., Winstock, A., Chaar, B. (2015). Senior nurses' perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacy. Drug and Alcohol Review, 34(5), 495-498. [More Information]
• Hamid, K., Ng, I., Tallapragada, V., Hibbs, D., Hanrahan, J., Groundwater, P. (2015). The Differential Effects of Resveratrol and trans-e-Viniferin on the GABA-Induced Current in GABAA Receptor Subtypes Expressed in Xenopus Laevis Oocytes. Journal of Pharmacy and Pharmaceutical Sciences, 18(4), 328-338. [More Information]
• Chua, H., Absalom, N., Hanrahan, J., Viswas, R., Chebib, M. (2015). The Direct Actions of GABA, 2-Methoxy-6-Methylflavone and General Anaesthetics at β3γ2L GABAA Receptors: Evidence for Receptors with Different Subunit Stoichiometries. PloS One, 10(10), 1-19. [More Information]
• Samad, A., Adeel, M., Khan, D., Badshah, S., Muhammad, Z., Khan, S., Hanrahan, J. (2015). Two New Bioactive Furoquinoline Alkaloids from Zanthoxylum armatum. Asian Journal of Chemistry, 27(7), 2468-2472. [More Information]

2014

• Abdelhalim, A., Chebib, M., Aburjai, T., Johnston, G., Hanrahan, J. (2014). GABAA Receptor Modulation by Compounds Isolated from Salvia triloba L. Advances in Biological Chemistry, 4(2), 148-159. [More Information]
• Blednov, Y., Benavidez, J., Black, M., Leiter, C., Osterndoff-Kahanek, E., Johnson, D., Borghese, C., Hanrahan, J., Johnston, G., Chebib, M., et al (2014). GABAA Receptors Containing p1 Subunits Contribute to In Vivo Effects of Ethanol in Mice. PloS One, 9(1), 1-16. [More Information]
• Hall, B., Karim, N., Chebib, M., Johnston, G., Hanrahan, J. (2014). Modulation of Ionotropic GABA Receptors by 6-Methoxyflavanone and 6-Methoxyflavone. Neurochemical Research, 39, 1068-1078. [More Information]
• Samad, A., Badshah, S., Khan, D., Ali, F., Amanullah, M., Hanrahan, J. (2014). New prenylated carbazole alkaloids from Zanthoxylum armatum. Journal of Asian Natural Products Research, 16(12), 1126-1131. [More Information]

2013

• Gavande, N., Kim, H., Doddareddy, M., Johnston, G., Chebib, M., Hanrahan, J. (2013). Design, synthesis, and pharmacological evaluation of fluorescent and biotinylated antagonists of P1 GABA(c) receptors. ACS Medicinal Chemistry Letters, 4(4), 402-407. [More Information]
• Meng, Q., Roubin, R., Hanrahan, J. (2013). Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs. Journal of Ethnopharmacology, 148(1), 229-238. [More Information]
• Chaar, B., Wang, H., Day, C., Hanrahan, J., Winstock, A., Fois, R. (2013). Factors influencing pharmacy services in opioid substitution treatment. Drug and Alcohol Review, 32(4), 426-434. [More Information]
• Karim, N., Wellendorph, P., Absalom, N., Johnston, G., Hanrahan, J., Chebib, M. (2013). Potency of gaba at human recombinant gaba alpha receptors expressed in xenopus oocytes: a mini review. Amino Acids, 44(4), 1139-1149. [More Information]
• Locock, K., Yamamoto, I., Tran, P., Hanrahan, J., Chebib, M., Johnston, G., Allan, R. (2013). γ-Aminobutyric Acid(C) (GABAC) Selective Antagonists Derived from the Bioisosteric Modification of 4-Aminocyclopent-1-enecarboxylic Acid: Amides and Hydroxamates. Journal of Medicinal Chemistry, 56(13), 5626-5630. [More Information]

2012

• Karim, N., Curmi, J., Gavande, N., Johnston, G., Hanrahan, J., Tierney, L., Chebib, M. (2012). 2'-Methoxy-6-methylflavone: A novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA(A) receptors. British Journal of Pharmacology, 165(4), 880-896. [More Information]
• Akladios, F., Nadvi, N., Park, J., Hanrahan, J., Kapoor, V., Gorrell, M., Church, W. (2012). Design and synthesis of novel inhibitors of human kynurenine aminotransferase-I. Bioorganic & Medicinal Chemistry Letters, 22(4), 1579-1581. [More Information]
• Yamamoto, I., Absalom, N., Carland, J., Doddareddy, M., Gavande, N., Johnston, G., Hanrahan, J., Chebib, M. (2012). Differentiating Enantioselective Actions of GABOB: A Possible Role for Threonine 244 in the Binding Site of GABAC rho1 Receptors. ACS Chemical Neuroscience, 3(9), 665-673. [More Information]
• Nguyen, T., Howard, S., Hanrahan, J., Groundwater, P., Platts, J., Hibbs, D. (2012). Experimental and Theoretical Charge Density Distribution in a Host-Guest System: Synthetic Terephthaloyl Receptor Complexed to Adipic Acid. The Journal of Physical Chemistry A, 116, 5618-5628. [More Information]
• Mohammad, A., Hanrahan, J., Sainsbury, E., Chaar, B. (2012). Fitness to practise in pharmacy: a study of impairment in professional practice. International Journal of Clinical Pharmacy, 34(2), 330-341. [More Information]
• Fernandez, S., Karim, N., Mewett, K., Chebib, M., Johnston, G., Hanrahan, J. (2012). Flavan-3-ol esters: new agents for exploring modulatory sites on GABAA receptors. British Journal of Pharmacology, 165(4), 965-977. [More Information]
• Karim, N., Wellendorph, P., Absalom, N., Bang, L., Jensen, M., Hansen, M., Lee, H., Johnston, G., Hanrahan, J., Chebib, M. (2012). Low nanomolar GABA effects at extrasynaptic a4b1/b3d GABAA receptor subtypes indicate a different binding mode for GABA at these receptors. Biochemical Pharmacology, 84(4), 549-557. [More Information]
• Yamamoto, I., Carland, J., Locock, K., Gavande, N., Absalom, N., Hanrahan, J., Allan, R., Johnston, G., Chebib, M. (2012). Structurally Diverse GABA Antagonists Interact Differently with Open and Closed Conformational States of the p1 Receptor. ACS Chemical Neuroscience, 3(4), 293-301. [More Information]
• Hanrahan, J. (2012). Sunscreens. Australian Prescriber, 35(5), 148-151. [More Information]

2011

• Karim, N., Gavande, N., Wellendorph, P., Johnston, G., Hanrahan, J., Chebib, M. (2011). 3-Hydroxy-2'-methoxy-6-methylflavone: A potent anxiolytic with a unique selectivity profile at GABBA receptor subtypes. Biochemical Pharmacology, 82(12), 1971-1983. [More Information]
• Chaar, B., Brien, J., Hanrahan, J., McLachlan, A., Penm, J., Pont, L. (2011). Experimental Education in Australian Pharmacy: Preceptors' Perspectives. Pharmacy Education, 11(1), 166-171.
• Hanrahan, J., Chebib, M., Johnston, G. (2011). Flavonoid modulation of GABA(A) receptors. British Journal of Pharmacology, 163(2), 234-245. [More Information]
• Gavande, N., Karim, N., Johnston, G., Hanrahan, J., Chebib, M. (2011). Identification of Benzopyran-4-one Derivatives (Isoflavones) as Positive Modulators of GABAA Receptors. ChemMedChem: chemistry enabling drug discovery, 6(8), 1340-1346. [More Information]
• Ng, C., Kim, H., Gavande, N., Yamamoto, I., Kumar, R., Mewett, K., Johnston, G., Hanrahan, J., Chebib, M. (2011). Medicinal Chemistry of p GABAc Receptors. Future Medicinal Chemistry, 3(2), 197-209. [More Information]
• Yow, T., Pera, E., Absalom, N., Heblinski, M., Johnston, G., Hanrahan, J., Chebib, M. (2011). Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. British Journal of Pharmacology, 163(5), 1017-1033. [More Information]
• Gavande, N., Yamamoto, I., Salam, N., Tu-Hoa, A., Burden, P., Johnston, G., Hanrahan, J., Chebib, M. (2011). Novel Cyclic Phosphinic Acids as GABAC F Receptor Antagonists: Design, Synthesis, and Pharmacology. ACS Medicinal Chemistry Letters, 2(1), 11-16. [More Information]
• Chaar, B., Hanrahan, J., Day, C. (2011). Provision of Opioid Substitution Therapy Services in Australian Pharmacies. Australasian Medical Journal, 4(4), 210-216. [More Information]

2010

• Nasrallah, F., Maher, A., Hanrahan, J., Balcar, V., Rae, C. (2010). Gamma-Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB. Journal of Neurochemistry, 115(1), 58-67. [More Information]
• Gavande, N., Johnston, G., Hanrahan, J., Chebib, M. (2010). Microwave-enhanced synthesis of 2,3,6-trisubstituted pyridazines: Application to four-step synthesis of gabazine (SR-95531). Organic and Biomolecular Chemistry, 8(18), 4131-4136. [More Information]
• Johnston, G., Chebib, M., Hanrahan, J., Mewett, K. (2010). Neurochemicals for the Investigation of GABAc Receptors. Neurochemical Research, 35(12), 1970-1977. [More Information]

2009

• Matin, A., Gavande, N., Kim, M., Yang, N., Salam, N., Hanrahan, J., Roubin, R., Hibbs, D. (2009). 7-Hydroxy-benzopyran-4-one Derivatives: A Novel Pharmacophore of Peroxisome Proliferator-Activated Receptor and - (PPAR and ) Dual Agonists. Journal of Medicinal Chemistry, 52(21), 6835-6850. [More Information]
• Ryan, G., Hanrahan, J., Krass, I., Sainsbury, E., Smith, L. (2009). Best Practices Assessment to Guide Curricular Change in a Bachelor of Pharmacy Program. American Journal of Pharmaceutical Education, 73(1), 1-8. [More Information]
• Meng, Q., Niu, Y., Niu, X., Roubin, R., Hanrahan, J. (2009). Ethnobotany, phytochemistry and pharmacology of the genus Caragana used in traditional Chinese medicine. Journal of Ethnopharmacology, 124(3), 350-368. [More Information]
• Chebib, M., Gavande, N., Wong, K., Park, A., Premoli, I., Mewett, K., Allan, R., Duke, R., Johnston, G., Hanrahan, J. (2009). Guanidino Acids Act as p1 GABAc Receptor Antagonists. Neurochemical Research, 34(10), 1704-1711. [More Information]
• Chebib, M., Hanrahan, J., Johnston, G. (2009). Neurologically-active Compounds (II). Patent No. 2002364767.
• Hanrahan, J., Johnston, G., Kumar, R., Chebib, M. (2009). Neurologically-active Compounds (III). Patent No. 1773740.
• Chebib, M., Hinton, T., Schmid, K., Brinkworth, D., Qian, H., Matos, S., Kim, H., Abdel-Halim, H., Kumar, R., Johnston, G., Hanrahan, J. (2009). Novel, potent and selective GABAC antagonists inhibit myopia development and facilitate learning and memory. Journal of Pharmacology and Experimental Therapeutics, 328(2), 448-457. [More Information]
• Mewett, K., Fernandez, S., Pasricha, A., Pong, A., Devenish, S., Hibbs, D., Chebib, M., Johnston, G., Hanrahan, J. (2009). Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABAA receptors. Bioorganic and Medicinal Chemistry, 17(20), 7156-7173. [More Information]
• Hanrahan, J., Johnston, G. (2009). Synthesis of -Aminobutyric Acid Analogs. In Hughes, A.B. (Eds.), Amino Acids, Peptides and Proteins in Organic Chemistry Volume 1 Origins and Synthesis of Amino Acids, (pp. 573-689). Weinheim, Germany: Wiley - V C H Verlag GmbH & Co. KGaA. [More Information]
• Fernandez, S., Nguyen, M., Yow, T., Chu, C., Johnston, G., Hanrahan, J., Chebib, M. (2009). The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice. Neurochemical Research, 34(10), 1867-1875. [More Information]

2008

• Abdel-Halim, H., Hanrahan, J., Hibbs, D., Johnston, G., Chebib, M. (2008). A molecular basis for agonist and antagonist actions at GABA(C) receptors. Chemical Biology and Drug Design (Print), 71(4), 306-327. [More Information]
• Fernandez, S., Mewett, K., Hanrahan, J., Chebib, M., Johnston, G. (2008). Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice. Neuropharmacology, 55(5), 900-907. [More Information]
• Kumar, R., Chebib, M., Hibbs, D., Kim, H., Johnston, G., Salam, N., Hanrahan, J. (2008). Novel gamma-aminobutyric acid rho(1) receptor antagonists; Synthesis, pharmacological activity and structure-activity relationships. Journal of Medicinal Chemistry, 51(13), 3825-3840. [More Information]

2007

• Chebib, M., Hanrahan, J., Kumar, R., Mewett, K., Morriss, G., Wooller, S., Johnston, G. (2007). (3-Aminocyclopentyl)methylphosphinic acids: Novel GABA(C) receptor antagonists. Neuropharmacology, 52(3), 779-787. [More Information]

2006

• Hanrahan, J., Mewett, K., Chebib, M., Matos, S., Eliopoulos, C., Crean, C., Kumar, R., Burden, P., Johnston, G. (2006). Diastereoselective synthesis of (+/-)-(3-aminocyclopentane)alkylphosphinic acids, conformationally restricted analogues of GABA. Organic and Biomolecular Chemistry, 4(13), 2642-2649. [More Information]
• Johnston, G., Hanrahan, J., Chebib, M., Duke, R., Mewett, K. (2006). Modulation of ionotropic GABA receptors by natural products of plant origin. Advances in Pharmacology, 54, 285-316. [More Information]

2005

• Hall, B., Chebib, M., Hanrahan, J., Johnston, G. (2005). 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes. European Journal of Pharmacology, 512(2-3), 97-104. [More Information]
• Chebib, M., Hanrahan, J., Johnston, G., Kumar, R. (2005). Patent No. 6962907.
• Crittenden, D., Kumar, R., Hanrahan, J., Chebib, M., Jordan, M. (2005). Stabilization of zwitterions in solution: Phosphinic and phosphonic acid GABA analogues. The Journal of Physical Chemistry A, 109(37), 8398-8409. [More Information]

2004

• Hall, B., Chebib, M., Hanrahan, J., Johnston, G. (2004). Flumazenil-independent positive modulation of g-aminobutyric acid action by 6-methylflavone at human recombinant a1h2g2L and a1h2 GABAA receptors. European Journal of Pharmacology, 491(1), 1-8. [More Information]
• Chebib, M., Hanrahan, J., Mewett, K., Duke, R., Johnston, G. (2004). Ionotropic Gaba Receptors As Therapeutic Targets For Memory And Sleep Disorders. Annual Reports in Medicinal Chemistry, 39(1), 13-23. [More Information]
• Carland, J., Moore, A., Hanrahan, J., Mewett, K., Duke, R., Johnston, G., Chebib, M. (2004). Mutations Of The 2' Proline In The M2 Domain Of The Human Gabac Rho1 Subunit Alter Agonist Responses. Neuropharmacology, 46, 770-781. [More Information]
• Allan, R., Greenwood, J., Hambley, T., Hanrahan, J., Hibbs, D., Itani, S., Tran, H., Turner, P. (2004). Studies On Pyridazine Azide Cyclisation Reactions. Organic and Biomolecular Chemistry, 2(12), 1782-8-1788. [More Information]

2003

• Hibbs, D., Hanrahan, J., Hursthouse, M., Knight, D., Overgaard, J., Turner, P., Piltz, R., Waller, M. (2003). Experimental and theoretical charge distribution in (Z)-N-methyl-C-phenylnitrone. Organic and Biomolecular Chemistry, 11(6), 1034-1040. [More Information]
• Waller, M., Hibbs, D., Overgaard, J., Hanrahan, J., Hambley, T. (2003). Flavone. Acta Crystallographica. Section E: Structure Reports Online, 59(6), o767-o768. [More Information]
• Johnston, G., Chebib, M., Hanrahan, J., Mewett, K. (2003). GABAc receptors as drug targets. CNS and Neurological Disorders, 2(4), 260-268.
• Hanrahan, J., Chebib, M., Davucheron, N., Hall, B., Johnston, G. (2003). Semisynthetic preparation of amentoflavone: a negative modulator at gabaa receptors. Bioorganic and Medicinal Chemistry Letters, 13(14), 2281-2284. [More Information]

2002

• Campbell, E., Chebib, M., Duke, R., Hall, B., Hanrahan, J., Johnston, G., Mewett, K. (2002). Epigallocatechin gallate, from green tea, and related agents as modulators of human brain GABA receptors. 5th Australia/Japan Symposium on Drug Design and Development.

2001

• Hall, B., Hanrahan, J., Johnston, G., Hambley, T., Hibbs, D. (2001). 6-Methylflavone. Acta Crystallographica. Section E: Structure Reports Online, E57.
• Hanrahan, J., Mewett, K., Chebib, M., Burden, P., Johnston, G. (2001). An improved, versatile synthesis of the GABAc antagonists (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) and (piperidin-4-yl)methylphosphinic acid (P4MPA). Royal Chemical Society. Journal. Perkin Transactions 1, 1, 2389-2392. [More Information]